Gland Pharma Live BSE/NSE | Gland Pharma Fundamenta data | Gland Pharma Balance sheet | Gland Pharma Quarterly Results | Gland Pharma Profit & Loss

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

35,719.17
46.22
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

34,398.94
N/A
3.53

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

10 Years
5 Years
3 Years

19.12
14.33
-

EBITDA CAGR (%)

10 Years
5 Years
3 Years

23.52
13.73
-

PAT CAGR (%)

10 Years
5 Years
3 Years

24.40
19.77
-

P:E (Median)

8 Years
5 Years
3 Years

P:BV (Average)

8 Years
5 Years
3 Years

EV:EBITDA (Average)

8 Years
5 Years
3 Years

Quarterly Results

Standalone Figures in Rs. Crores

Description Dec 20 Dec 19 Var% Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var%
Net Sales 859.42 645.94 33.05% 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Expenses 595.19 434.16 37.09% 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBITDA 264.23 211.77 24.77% 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIDTM 30.75% 32.79% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 35.13 25.29 38.91% 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Interest 1.16 5.68 -79.58% 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 24.96 24.23 3.01% 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT 273.24 207.15 31.90% 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Tax 69.13 53.05 30.31% 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 204.11 154.10 32.45% 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PATM 23.75% 23.86% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 12.50 9.44 32.42% 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Description Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var%
Net Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Expenses 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBITDA 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Annual Results

Standalone Figures in Rs. Crores

Description TTM Mar 20 Mar 19 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10 Mar 09
Net Sales - 2,633.24 2,044.20 1,347.87 993.80 990.92 769.68 526.67 457.90 207.15 164.07 Net Sales Growth - 28.82% 51.66% 35.63% 0.29% 28.74% 46.14% 15.02% 121.05% 26.26% Cost Of Goods Sold - 836.07 626.35 540.21 414.04 412.46 370.68 286.56 258.62 90.34 70.92 Gross Profit - 1,797.18 1,417.85 807.66 579.75 578.46 399.00 240.11 199.29 116.81 93.15 GP Margin - 68.25% 69.36% 59.92% 58.34% 58.38% 51.84% 45.59% 43.52% 56.39% 56.77% Total Expenditure - 1,677.77 1,337.89 845.63 677.60 630.31 535.78 393.58 342.32 153.62 123.00 Power & Fuel Cost - 78.50 74.03 46.96 42.72 36.07 25.05 12.32 9.67 7.32 6.61 % Of Sales - 2.98% 3.62% 3.48% 4.30% 3.64% 3.25% 2.34% 2.11% 3.53% 4.03% Employee Cost - 277.66 222.95 131.30 105.69 81.44 65.78 46.00 34.71 24.14 20.62 % Of Sales - 10.54% 10.91% 9.74% 10.63% 8.22% 8.55% 8.73% 7.58% 11.65% 12.57% Manufacturing Exp. - 391.88 337.81 71.62 61.08 55.68 23.92 16.04 12.63 7.33 10.66 % Of Sales - 14.88% 16.53% 5.31% 6.15% 5.62% 3.11% 3.05% 2.76% 3.54% 6.50% General & Admin Exp. - 57.77 47.00 34.24 32.08 29.60 18.64 10.19 7.56 10.89 7.67 % Of Sales - 2.19% 2.30% 2.54% 3.23% 2.99% 2.42% 1.93% 1.65% 5.26% 4.67% Selling & Distn. Exp. - 17.08 13.88 15.80 16.41 12.18 9.89 8.07 6.27 13.61 6.52 % Of Sales - 0.65% 0.68% 1.17% 1.65% 1.23% 1.28% 1.53% 1.37% 6.57% 3.97% Miscellaneous Exp. - 18.82 15.86 5.52 5.58 2.90 21.81 14.40 12.87 0.00 6.52 % Of Sales - 0.71% 0.78% 0.41% 0.56% 0.29% 2.83% 2.73% 2.81% 0% 0% EBITDA - 955.47 706.31 502.24 316.20 360.61 233.90 133.09 115.58 53.53 41.07 EBITDA Margin - 36.28% 34.55% 37.26% 31.82% 36.39% 30.39% 25.27% 25.24% 25.84% 25.03% Other Income - 139.17 85.56 36.76 29.65 8.54 1.11 13.88 9.74 6.78 10.13 Interest - 7.18 3.56 16.42 16.69 13.38 6.36 2.77 3.77 3.54 5.22 Depreciation - 94.59 81.96 63.46 56.72 28.42 14.57 10.82 9.24 8.97 7.37 PBT - 992.87 706.36 459.11 272.43 327.34 214.08 133.39 112.31 47.79 38.61 Tax - 220.01 234.45 145.51 63.16 103.47 55.99 32.16 25.21 11.31 8.37 Tax Rate - 22.16% 34.16% 31.69% 23.18% 31.61% 26.15% 24.11% 22.45% 23.67% 21.68% PAT - 772.86 451.91 313.61 209.27 223.88 158.09 101.23 87.10 36.49 30.24 PAT before Minority Interest - 772.86 451.91 313.61 209.27 223.88 158.09 101.23 87.10 36.49 30.24 Minority Interest - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin - 29.35% 22.11% 23.27% 21.06% 22.59% 20.54% 19.22% 19.02% 17.62% 18.43% PAT Growth - 71.02% 44.10% 49.86% -6.53% 41.62% 56.17% 16.22% 138.70% 20.67% Unadjusted EPS - 47.33 27.67 19.20 12.82 13.71 9.68 6.20 5.33 2.23 1.85

Description

TTM

Mar 20

Mar 19

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Mar 10

Mar 09

Net Sales

2,633.24

2,044.20

1,347.87

993.80

990.92

769.68

526.67

457.90

207.15

164.07

Net Sales Growth

28.82%

51.66%

35.63%

0.29%

28.74%

46.14%

15.02%

121.05%

26.26%

Cost Of Goods Sold

836.07

626.35

540.21

414.04

412.46

370.68

286.56

258.62

90.34

70.92

Gross Profit

1,797.18

1,417.85

807.66

579.75

578.46

399.00

240.11

199.29

116.81

93.15

GP Margin

68.25%

69.36%

59.92%

58.34%

58.38%

51.84%

45.59%

43.52%

56.39%

56.77%

Total Expenditure

1,677.77

1,337.89

845.63

677.60

630.31

535.78

393.58

342.32

153.62

123.00

Power & Fuel Cost

78.50

74.03

46.96

42.72

36.07

25.05

12.32

9.67

7.32

6.61

% Of Sales

2.98%

3.62%

3.48%

4.30%

3.64%

3.25%

2.34%

2.11%

3.53%

4.03%

Employee Cost

277.66

222.95

131.30

105.69

81.44

65.78

46.00

34.71

24.14

20.62

% Of Sales

10.54%

10.91%

9.74%

10.63%

8.22%

8.55%

8.73%

7.58%

11.65%

12.57%

Manufacturing Exp.

391.88

337.81

71.62

61.08

55.68

23.92

16.04

12.63

7.33

10.66

% Of Sales

14.88%

16.53%

5.31%

6.15%

5.62%

3.11%

3.05%

2.76%

3.54%

6.50%

General & Admin Exp.

57.77

47.00

34.24

32.08

29.60

18.64

10.19

7.56

10.89

7.67

% Of Sales

2.19%

2.30%

2.54%

3.23%

2.99%

2.42%

1.93%

1.65%

5.26%

4.67%

Selling & Distn. Exp.

17.08

13.88

15.80

16.41

12.18

9.89

8.07

6.27

13.61

6.52

% Of Sales

0.65%

0.68%

1.17%

1.65%

1.23%

1.28%

1.53%

1.37%

6.57%

3.97%

Miscellaneous Exp.

18.82

15.86

5.52

5.58

2.90

21.81

14.40

12.87

0.00

6.52

% Of Sales

0.71%

0.78%

0.41%

0.56%

0.29%

2.83%

2.73%

2.81%

EBITDA

955.47

706.31

502.24

316.20

360.61

233.90

133.09

115.58

53.53

41.07

EBITDA Margin

36.28%

34.55%

37.26%

31.82%

36.39%

30.39%

25.27%

25.24%

25.84%

25.03%

Other Income

139.17

85.56

36.76

29.65

8.54

1.11

13.88

9.74

6.78

10.13

Interest

7.18

3.56

16.42

16.69

13.38

6.36

2.77

3.77

3.54

5.22

Depreciation

94.59

81.96

63.46

56.72

28.42

14.57

10.82

9.24

8.97

7.37

PBT

992.87

706.36

459.11

272.43

327.34

214.08

133.39

112.31

47.79

38.61

Tax

220.01

234.45

145.51

63.16

103.47

55.99

32.16

25.21

11.31

8.37

Tax Rate

22.16%

34.16%

31.69%

23.18%

31.61%

26.15%

24.11%

22.45%

23.67%

21.68%

PAT

772.86

451.91

313.61

209.27

223.88

158.09

101.23

87.10

36.49

30.24

PAT before Minority Interest

772.86

451.91

313.61

209.27

223.88

158.09

101.23

87.10

36.49

30.24

Minority Interest

0.00

PAT Margin

29.35%

22.11%

23.27%

21.06%

22.59%

20.54%

19.22%

19.02%

17.62%

18.43%

PAT Growth

71.02%

44.10%

49.86%

-6.53%

41.62%

56.17%

16.22%

138.70%

20.67%

Unadjusted EPS

47.33

27.67

19.20

12.82

13.71

9.68

6.20

5.33

2.23

1.85

Results Balance Sheet

Standalone Figures in Rs. Crores

Description Mar 20 Mar 19 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10 Mar 09
Shareholder's Funds 3,646.24 2,862.11 833.65 609.77 451.68 350.45 263.35 226.52 Share Capital 15.49 15.49 11.76 11.76 11.76 11.76 11.76 11.76 Total Reserves 3,614.26 2,846.62 821.89 598.01 439.92 338.69 251.59 214.76 Non-Current Liabilities 80.78 127.79 132.29 65.12 30.43 33.42 58.55 74.81 Secured Loans 0.00 0.00 85.36 32.76 2.68 9.01 36.70 54.48 Unsecured Loans 4.07 4.96 6.94 7.05 6.70 5.70 5.29 4.50 Long Term Provisions 0.00 0.00 0.41 1.71 0.54 0.63 0.00 0.00 Current Liabilities 359.02 532.68 320.66 243.09 235.93 198.54 77.68 20.81 Trade Payables 249.09 446.20 98.47 48.41 53.65 30.32 7.48 12.78 Other Current Liabilities 81.73 72.60 162.99 105.56 104.70 118.05 58.42 0.00 Short Term Borrowings 0.00 0.00 58.26 85.04 75.08 47.23 0.00 0.00 Short Term Provisions 28.20 13.88 0.92 4.08 2.50 2.95 11.79 8.03 Total Liabilities 4,086.04 3,522.58 1,286.60 917.98 718.04 582.41 399.58 322.14 Net Block 968.10 928.74 459.74 308.56 206.20 167.89 153.96 143.08 Gross Block 1,347.81 1,219.58 565.31 385.79 269.29 224.69 201.57 181.79 Accumulated Depreciation 379.71 290.83 105.57 77.23 63.08 56.80 47.61 38.71 Non Current Assets 1,239.75 1,165.13 689.53 520.54 351.57 235.47 173.01 155.18 Capital Work in Progress 188.47 123.16 207.88 208.01 142.75 65.99 19.02 12.11 Non Current Investment 0.00 0.00 0.05 0.05 0.03 0.03 0.03 0.00 Long Term Loans & Adv. 81.52 111.89 21.51 3.92 2.60 1.57 0.00 0.00 Other Non Current Assets 1.66 1.33 0.35 0.00 0.00 0.00 0.00 0.00 Current Assets 2,846.29 2,357.46 597.06 397.45 366.46 346.93 226.58 166.96 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 756.28 911.88 306.36 167.65 180.46 199.36 115.19 51.02 Sundry Debtors 601.78 506.10 168.20 127.91 92.08 74.10 43.90 39.98 Cash & Bank 1,325.19 753.35 77.10 91.65 84.07 64.03 49.89 63.32 Other Current Assets 163.03 54.19 25.36 0.89 9.85 9.44 17.60 12.64 Short Term Loans & Adv. 91.80 131.94 20.04 9.35 9.05 8.58 10.97 6.75 Net Current Assets 2,487.27 1,824.78 276.41 154.36 130.53 148.39 148.89 146.15 Total Assets 4,086.04 3,522.59 1,286.59 917.99 718.03 582.40 399.59 322.14

Description

Mar 20

Mar 19

Mar 14

Mar 13

Mar 12

Mar 11

Mar 10

Mar 09

Shareholder's Funds

3,646.24

2,862.11

833.65

609.77

451.68

350.45

263.35

226.52

Share Capital

15.49

11.76

Total Reserves

3,614.26

2,846.62

821.89

598.01

439.92

338.69

251.59

214.76

Non-Current Liabilities

80.78

127.79

132.29

65.12

30.43

33.42

58.55

74.81

Secured Loans

0.00

85.36

32.76

2.68

9.01

36.70

54.48

Unsecured Loans

4.07

4.96

6.94

7.05

6.70

5.70

5.29

4.50

Long Term Provisions

0.00

0.41

1.71

0.54

0.63

0.00

Current Liabilities

359.02

532.68

320.66

243.09

235.93

198.54

77.68

20.81

Trade Payables

249.09

446.20

98.47

48.41

53.65

30.32

7.48

12.78

Other Current Liabilities

81.73

72.60

162.99

105.56

104.70

118.05

58.42

0.00

Short Term Borrowings

0.00

58.26

85.04

75.08

47.23

0.00

Short Term Provisions

28.20

13.88

0.92

4.08

2.50

2.95

11.79

8.03

Total Liabilities

4,086.04

3,522.58

1,286.60

917.98

718.04

582.41

399.58

322.14

Net Block

968.10

928.74

459.74

308.56

206.20

167.89

153.96

143.08

Gross Block

1,347.81

1,219.58

565.31

385.79

269.29

224.69

201.57

181.79

Accumulated Depreciation

379.71

290.83

105.57

77.23

63.08

56.80

47.61

38.71

Non Current Assets

1,239.75

1,165.13

689.53

520.54

351.57

235.47

173.01

155.18

Capital Work in Progress

188.47

123.16

207.88

208.01

142.75

65.99

19.02

12.11

Non Current Investment

0.00

0.05

0.03

0.00

Long Term Loans & Adv.

81.52

111.89

21.51

3.92

2.60

1.57

0.00

Other Non Current Assets

1.66

1.33

0.35

0.00

Current Assets

2,846.29

2,357.46

597.06

397.45

366.46

346.93

226.58

166.96

Current Investments

0.00

Inventories

756.28

911.88

306.36

167.65

180.46

199.36

115.19

51.02

Sundry Debtors

601.78

506.10

168.20

127.91

92.08

74.10

43.90

39.98

Cash & Bank

1,325.19

753.35

77.10

91.65

84.07

64.03

49.89

63.32

Other Current Assets

163.03

54.19

25.36

0.89

9.85

9.44

17.60

12.64

Short Term Loans & Adv.

91.80

131.94

20.04

9.35

9.05

8.58

10.97

6.75

Net Current Assets

2,487.27

1,824.78

276.41

154.36

130.53

148.39

148.89

146.15

Total Assets

4,086.04

3,522.59

1,286.59

917.99

718.03

582.40

399.59

322.14

Cash Flow

Standalone Figures in Rs. Crores

Description Mar 20 Mar 19 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10 Mar 09
Cash From Operating Activity 700.93 185.06 130.43 154.71 112.96 58.10 26.81 10.30 PBT 992.87 686.36 327.34 214.08 133.39 112.31 47.79 38.61 Adjustment 32.15 76.12 34.81 13.51 -2.40 -0.46 5.75 2.48 Changes in Working Capital -79.94 -353.94 -148.29 -49.43 3.39 -46.71 -19.54 -21.73 Cash after chg. in Working capital 945.07 408.53 213.87 178.16 134.37 65.14 34.00 19.36 Interest Paid 0.00 0.00 8.11 6.36 2.77 3.77 0.00 0.00 Tax Paid -244.14 -223.47 -91.55 -29.81 -24.18 -10.81 -7.19 -9.06 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -766.08 -314.14 -190.31 -181.16 -112.67 -60.44 -20.04 -21.93 Net Fixed Assets -193.54 -569.55 -179.39 -181.76 -121.36 -70.09 -26.69 Net Investments 0.00 0.05 0.00 -0.02 0.00 0.00 -0.03 Others -572.54 255.36 -10.92 0.62 8.69 9.65 6.68 Cash from Financing Activity -6.87 -2.93 46.99 34.03 19.75 16.48 -20.19 -15.86 Net Cash Inflow / Outflow -72.01 -132.01 -12.89 7.58 20.04 14.13 -13.43 -27.48 Opening Cash & Equivalents 236.40 372.84 90.33 84.07 64.03 49.89 63.32 90.80 Closing Cash & Equivalent 169.50 236.40 76.04 91.65 84.07 64.03 49.89 63.32

Description

Mar 20

Mar 19

Mar 14

Mar 13

Mar 12

Mar 11

Mar 10

Mar 09

Cash From Operating Activity

700.93

185.06

130.43

154.71

112.96

58.10

26.81

10.30

PBT

992.87

686.36

327.34

214.08

133.39

112.31

47.79

38.61

Adjustment

32.15

76.12

34.81

13.51

-2.40

-0.46

5.75

2.48

Changes in Working Capital

-79.94

-353.94

-148.29

-49.43

3.39

-46.71

-19.54

-21.73

Cash after chg. in Working capital

945.07

408.53

213.87

178.16

134.37

65.14

34.00

19.36

Interest Paid

0.00

8.11

6.36

2.77

3.77

0.00

Tax Paid

-244.14

-223.47

-91.55

-29.81

-24.18

-10.81

-7.19

-9.06

Other Direct Exp. Paid

0.00

Extra & Other Items

0.00

Cash From Investing Activity

-766.08

-314.14

-190.31

-181.16

-112.67

-60.44

-20.04

-21.93

Net Fixed Assets

-193.54

-569.55

-179.39

-181.76

-121.36

-70.09

-26.69

Net Investments

0.00

0.05

0.00

-0.02

0.00

-0.03

Others

-572.54

255.36

-10.92

0.62

8.69

9.65

6.68

Cash from Financing Activity

-6.87

-2.93

46.99

34.03

19.75

16.48

-20.19

-15.86

Net Cash Inflow / Outflow

-72.01

-132.01

-12.89

7.58

20.04

14.13

-13.43

-27.48

Opening Cash & Equivalents

236.40

372.84

90.33

84.07

64.03

49.89

63.32

90.80

Closing Cash & Equivalent

169.50

236.40

76.04

91.65

84.07

64.03

49.89

63.32

Financial Ratios

Standalone

Description Mar 20 Mar 19 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10 Mar 09
Book Value (Rs.) 234.25 1847.12 708.98 518.58 384.13 298.04 223.97 192.65 ROA 20.32% 14.01% 20.31% 19.33% 15.57% 17.74% 10.11% 9.39% ROE 23.81% 17.14% 31.02% 29.79% 25.24% 28.38% 14.90% 13.35% ROCE 30.68% 26.11% 39.05% 34.48% 28.18% 31.89% 17.38% 15.35% Fixed Asset Turnover 2.05 1.80 2.10 2.35 2.13 2.15 1.08 0.90 Receivable days 76.78 87.61 54.15 52.16 57.58 47.03 73.90 88.95 Inventory Days 115.61 127.19 86.69 82.54 131.62 125.37 146.44 113.50 Payable days 73.57 99.56 43.51 36.21 40.30 20.13 23.29 37.67 Cash Conversion Cycle 118.83 115.24 97.33 98.49 148.90 152.27 197.05 164.77 Total Debt/Equity 0.00 0.00 0.21 0.21 0.20 0.21 0.16 0.26 Interest Cover 139.24 193.80 25.47 34.64 49.17 30.79 14.49 8.40

Description

Mar 20

Mar 19

Mar 14

Mar 13

Mar 12

Mar 11

Mar 10

Mar 09

Book Value (Rs.)

234.25

1847.12

708.98

518.58

384.13

298.04

223.97

192.65

ROA

20.32%

14.01%

20.31%

19.33%

15.57%

17.74%

10.11%

9.39%

ROE

23.81%

17.14%

31.02%

29.79%

25.24%

28.38%

14.90%

13.35%

ROCE

30.68%

26.11%

39.05%

34.48%

28.18%

31.89%

17.38%

15.35%

Fixed Asset Turnover

2.05

1.80

2.10

2.35

2.13

2.15

1.08

0.90

Receivable days

76.78

87.61

54.15

52.16

57.58

47.03

73.90

88.95

Inventory Days

115.61

127.19

86.69

82.54

131.62

125.37

146.44

113.50

Payable days

73.57

99.56

43.51

36.21

40.30

20.13

23.29

37.67

Cash Conversion Cycle

118.83

115.24

97.33

98.49

148.90

152.27

197.05

164.77

Total Debt/Equity

0.00

0.21

0.20

0.21

0.16

0.26

Interest Cover

139.24

193.80

25.47

34.64

49.17

30.79

14.49

8.40

Gland Pharma Ltd.

Pharmaceuticals & Drugs

BSE: 543245 | NSE: GLAND

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Annual Reports:

News Update

Gland Pharma Ltd.

Pharmaceuticals & Drugs

BSE: 543245 | NSE: GLAND

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Annual Reports:

News Update